Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This continues for 6 weeks, with reassessment at the midpoint
This remains preliminary, but it aligns with broader evidence linking GH-IGF-1 signalling to neurological health in ageing populations
Ready to boost your B12 levels
According to CNN, more than 70% of semaglutide prescriptions have gone to White patients White people are about four times more likely than Black people to have a prescription for a semaglutide medication, despite having nearly a 40% lower prevalence of diabetes and a 17% lower prevalence of obesity. So, White patients are receiving the vast majority of semaglutide prescriptions (Ozempic and Wegovy) by percentage, despite having a lower prevalence of both diabetes and obesity
doi: 10.1016/j.neuropharm.2013.06.004
These weight-loss drugs are set to boost Americas GDP by 1% by that year and command a $105B market by the end of the decade
